INS and Hyperglycemia: However, we acknowledge the following limitations (29): it is somewhat less accurate than the newer HOMA-2 model, it does not differentiate between peripheral and hepatic IR and does not take into account either the increase in insulin secretion that may occur in response to hyperglycemia or renal glucose losses as does the newer model and is more in line with older insulin assays.